Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep41624.pdf
Reference56 articles.
1. Jemal, A. et al. Global cancer statistics. CA: a cancer journal for clinicians 61, 69–90, doi: 10.3322/caac.20107 (2011).
2. Marelli, L. et al. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer treatment reviews 32, 594–606, doi: 10.1016/j.ctrv.2006.08.002 (2006).
3. Lei, J., Yan, L. & Wang, W. Donor safety in living donor liver transplantation: a single-center analysis of 300 cases. PloS one 8, e61769, doi: 10.1371/journal.pone.0061769 (2013).
4. Bruix, J. & Llovet, J. M. Major achievements in hepatocellular carcinoma. Lancet 373, 614–616, doi: 10.1016/S0140-6736(09)60381-0 (2009).
5. Lencioni, R., Chen, X. P., Dagher, L. & Venook, A. P. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? The oncologist 15 Suppl 4, 42–52, doi: 10.1634/theoncologist.2010-S4-42 (2010).
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigating the Influence of Preoperative Trans Arterial Embolization (TAE) and Predictive Potential of Circulating Tumor Cells (CTCs) in Prognosis of Hepatocellular Carcinoma;Journal of Clinical and Experimental Hepatology;2024-11
2. Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis;Liver Transplantation;2024-03-05
3. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-02
4. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-02
5. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3